肾脏病又称肾病。这是由于肾脏功能失调引起的。肾脏疾病有多种类型,包括肾结石、肾小球肾炎、尿路感染等。为了治疗和诊断这些类型的疾病,不同的全球和地区参与者正在提供各种产品和服务。
北美肾脏疾病市场预计将从 2019 年的 254.835 亿美元增至 2027 年的 424.621 亿美元。预计从 2020 年开始,该市场将以 6.7% 的复合年增长率增长-2027。市场的增长归因于一些关键驱动因素,例如慢性肾脏相关疾病的患病率增加和人口老龄化的高速增长。然而,由于肾脏疾病诊断失败,预计市场在预测期内增长缓慢。
从产品来看,肾病市场细分诊断和治疗。诊断部分进一步细分为血液检查、尿液检查、影像检查等。治疗部分进一步细分为透析、药物类别等。该药物类别细分为 ACE 抑制剂、血管紧张素 2 受体阻滞剂、利尿剂等。根据最终用户,肾脏疾病市场分为医院、诊断实验室等。
报告中包含的一些主要的肾脏疾病市场主要来源包括美国泌尿外科协会、国家肾脏基金会、肾脏国际报告< span> 和其他。
按产品
· 诊断
o 血液测试
o 尿液测试
o 成像测试
o 其他
· 治疗
o 透析
o 其他
o 药物类别
§ ACE抑制剂
§ 血管紧张素-II 受体阻滞剂
§ 利尿剂
§ 其他
最终用户
·   ; 医院
· 诊断实验室
· 其他
按国家/地区
· 北美
o 美国
o 加拿大
o 墨西哥
Strategic insights for North America Kidney Disease involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 25,483.5 Million |
Market Size by 2027 | US$ 42,462.1 Million |
Global CAGR (2020 - 2027) | 6.7% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Kidney Disease refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Kidney Disease Market
The North America Kidney Disease Market is valued at US$ 25,483.5 Million in 2019, it is projected to reach US$ 42,462.1 Million by 2027.
As per our report North America Kidney Disease Market, the market size is valued at US$ 25,483.5 Million in 2019, projecting it to reach US$ 42,462.1 Million by 2027. This translates to a CAGR of approximately 6.7% during the forecast period.
The North America Kidney Disease Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Kidney Disease Market report:
The North America Kidney Disease Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Kidney Disease Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Kidney Disease Market value chain can benefit from the information contained in a comprehensive market report.